Additionally, acquired periostin in breast cancer promotes tumor angiogenesis by upregulating the expression of endothelial growth factor receptor 2 (18) and use of a periostin antibody significantly inhibits tumor growth and angiogenesis in vivo (27). This evidence concerns the gene POSTN and breast cancer.